Yüklüyor......

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Recently developed genomics-based tools are allowing repositioning of Food and Drug Administration (FDA)-approved drugs as cancer treatments, which were employed to identify drugs that target cancer stem cells (CSCs) of breast cancer. Gene expression datasets of CSCs from six studies were subjected...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bhat-Nakshatri, Poornima, Goswami, Chirayu P., Badve, Sunil, Sledge, George W., Nakshatri, Harikrishna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3965360/
https://ncbi.nlm.nih.gov/pubmed/23982413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep02530
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!